Jay, since this threads conversation has turned to what was being discussed on another thread Ive merged the 2 together. I hope this isnt confusing for anyone reading as the flow isnt as easy to follow.

BTW... I looked up the study you mentioned. Lessening the rads to help patients manage dramatically less collateral damage to other nearby areas sure would have sounded good to me when I was suffering thru it. I definitely would have jumped at the chance too. But, having only 71 patients take part is a very small study. Then looking at the tumor locations, that significantly lowers it to far less who have similar located tumors. I cant remember if when I read thru the study earlier it had anyone who was being treated for multiple cases of SCC over the span of many years. That alone I would think would make you ineligible to lessen the course of rads.